documents: FDA-2010-N-0621-0359

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2010-N-0621-0359 FDA FDA-2010-N-0621 Avastin Final Presentation - "Administrative Hearing Proposal to Withdraw Accelerated Approval of Avastin for 1st Line Metastatic Breast Cancer" - [Proposal To Withdraw Approval for the Breast Cancer Indication for Bevacizumab; Hearing] Other Presentation 2011-06-30T04:00:00Z 2011 6 2011-06-30T04:00:00Z   2011-06-30T18:55:45Z   0 0 0900006480eb768e

Links from other tables